Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Rapifen CMI 26 Jul 2017
Mycamine PI 26 Jul 2017
Nucala CMI 25 Jul 2017
Sifrol ER CMI 25 Jul 2017
Sifrol CMI 25 Jul 2017

New products

Product name Type Date released
Azopt CMI 26 Jul 2017
Rhinocort Hayfever PI 24 Jul 2017
Rhinocort Hayfever CMI 24 Jul 2017
APO-Fluoxetine CMI 21 Jul 2017
APO-Fluoxetine PI 21 Jul 2017